Searched for
BAYER CANCER LAWSUITS
Top cases on the United States Supreme Court's docketThe U.S. Supreme Court is reviewing significant cases. These cases cover voting rights, presidential authority, immigration policies, and g...- US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claimsA US judge has dismissed Bayer's plea to halt Johnson & Johnson's advertising for its prostate cancer drug Erleada. Bayer alleged false cla...
- Trump issues order to support production of glyphosate: Why has US President’s executive order irked MAHA Moms? All you need to knowPresident Trump has ordered an increase in domestic glyphosate production, citing food security and national defense needs. This move, howe...
- Will Bayer's proposed $7.25 billion Roundup deal bring legal closure?Bayer's Monsanto division is making headlines with a bold offer of $7.25 billion to settle lawsuits concerning Roundup and its alleged link...
- Bayer says it has cut 12,000 jobs so far under restructuring pushBayer has eliminated approximately 12,000 full-time positions as part of its restructuring efforts aimed at streamlining operations and red...
- European shares edge higher at start of holiday-thinned weekEuropean shares were marginally higher on Wednesday as robust China data lifted miners, while an overnight Wall Street rally amid persistin...
- Beware! This popular artificial sweetener may be a carcinogenAspartame, used in products from Coca-Cola diet sodas to Mars' Extra chewing gum and some Snapple drinks, will be listed in July as "possib...
- WHO's cancer research agency to say aspartame sweetener a possible carcinogen: SourcesThe artificial sweetener aspartame is set to be declared a possible carcinogen by the International Agency for Research on Cancer (IARC), a...
- Weak Diageo, Bayer earnings hit Europe stocks; BP jumpsLeading gains among sectors, the oil & gas sector rose 2.1 per cent, while automakers, banks and travel & leisure rose between 1.5 per cent...
- Ahead of Market: 12 things that will decide stock action on FridayA look at what some of the key indicators are suggesting for Friday’s market action.
- European stocks tumble on concerns over recoveryThe pan-European STOXX 600 fell 1.1% by 0717 GMT, led lower by travel & leisure, bank and oil & gas stocks.
- Bayer Chairman quits after making progress to settle litigationBayer, which is fighting claims its weedkiller Roundup causes cancer, said its Chairman Werner Wenning was stepping down because the drugs ...
- Bayer’s move to block Natco’s colorectal cancer brand dismissed by Delhi HCBayer raised the objection against Natco’s brand launched under the name Regonat alleging infringement of its patent rights.
- US jury orders Monsanto to pay $290 million to cancer patient over weed killerFollowing eight weeks of trial proceedings, the San Francisco jury ordered Monsanto to pay USD 250 million in punitive damages along with c...
- Some of the most influential Dalal Street investors you’ve never heard aboutTheir long association and huge cache of shares make them very influential on D-Street as promoters dread their unwavering gaze.
- Delhi High Court notice to government over MNCs' patent disclosureThe petition exposes the weak enforcement of an important statutory provision, Form 27, which discloses patent data of a company.
- Why SC ruling won't bring down drug pricesDespite the SC verdict, Indian generics makers won't be falling over each other to take on Big Pharma and launch cheaper versions of their ...
- Curb prices of costly imported medicines before issuing compulsory licencesIt would safeguard India's ability to export drugs made under compulsory licences issued by a third country.
Load More
